Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar;40(3):859-66.
doi: 10.1002/eji.200939842.

T-bet, a Th1 transcription factor regulates the expression of Tim-3

Affiliations

T-bet, a Th1 transcription factor regulates the expression of Tim-3

Ana C Anderson et al. Eur J Immunol. 2010 Mar.

Abstract

T-cell immunoglobulin, mucin domain-3 (Tim-3) is a membrane protein expressed at late stages of IFN-gamma secreting CD4(+) Th1 cell differentiation and constitutively on DC. Ligation of Tim-3 on Th1 cells terminates Th1 immune responses. In addition, Tim-3 plays a role in tolerance induction, although the mechanism by which this is accomplished has yet to be elucidated. While it is clear that Tim-3 plays an important role in the immune system, little is known regarding the molecular pathways that regulate Tim-3 expression. In the current study, we examine the role of Th1-associated transcription factors in regulating Tim-3 expression. Our experiments reveal that Tim-3 expression is regulated by the Th1-specific transcription factor T-bet. This introduces a novel paradigm into the generation of a Th1 response, whereby a transcription factor responsible for effector Th1 cell differentiation also increases the expression of a specific counter-regulatory molecule to ensure appropriate termination of pro-inflammatory Th1 immune responses.

PubMed Disclaimer

Conflict of interest statement

Disclosure of Conflicts of Interest

VKK works with Telos Inc. which has funded part of this work. CAS and VKK hold a patent related to Tim-3 and Tim-3L. LHG has equity in and is on the corporate board of Bristol-Myers Squibb Company and is a paid consultant for HealthCare Ventures LLC Scientific Advisory Board and Mannkind Corporation. She has equity in MannKind Corporation and has filed patents that have been licensed by them.

Figures

Figure 1
Figure 1. Impaired Tim-3 expression in T-bet and STAT-4 deficient Th1 cells
(A) Naïve CD4+ (CD4+ CD62Lhigh) T cells from wild type, T-bet−/−, STAT-4−/− and T-bet−/− × STAT-4−/− mice were stimulated in vitro under Th1 polarizing conditions. After each round of polarization, cells were harvested and total RNA prepared for analysis of Tim-3 expression by real-time PCR. Expression of Tim-3 RNA relative to control HPRT expression is shown. Error bars indicate SEM of two replicate experiments. Data shown are representative of 2–3 independent experiments. (B) CD4+ T cells from (A) were activated with PMA/Ionomycin and then stained with mAbs to Tim-3, CD4, IFN-γ, IL-4, IL-10 and IL-17. Histograms represent Tim-3 expression (filled histogram, FMO control; solid black line, Tim-3 staining). Dot plots represent cytokine expression in CD4+ cells. Numbers indicate frequency of cytokine positive cells. Similar results were obtained in 2–3 independent experiments. (C) Median fluorescence intensity (MFI) of Tim-3 staining on CD4+ T cells from wildtype, T-bet−/−, STAT-4−/− and T-bet−/− × STAT-4−/− T cells after each round of in vitro Th1 differentiation. Data shown are representative of 2–3 independent experiments.
Figure 2
Figure 2
T-bet can drive the expression of Tim-3 independently of transactivation of IFN-γ. Naïve (CD4+CD62LhighCD25) CD4+ T cells from T-bet−/− × IFN-γ−/− mice were transduced at 48 hours post activation with plate bound CD3 and CD28 with either empty (RV GFP) or T-bet (RV T-bet) expressing retrovirus and sorted for CD4 and GFP expression at day 5. The cells were rested overnight in IL-2 (100 U/ml) and RNA was extracted 24 hours later. Tim-3 RNA expression was quantified by real time PCR and normalised to β-actin. Error bars represent SEM from triplicate PCRs. Data shown are representative of 3 independent experiments.
Figure 3
Figure 3. Impaired Tim-3 expression in T-bet and STAT-4 deficient dendritic cells
CD11c+ dendritic cells were isolated by cell sorting from the collagenase digested spleens of wild type, T-bet−/−, STAT-4−/− and T-bet−/− × STAT-4−/− mice. Expression of Tim-3 RNA relative to control HPRT expression is shown. Error bars indicate SEM of two replicate experiments. Data shown are representative of 2–3 independent experiments.
Figure 4
Figure 4. T-bet controls Tim-3 expression in vitro
Naïve CD4+ (CD4+CD62LhighCD25) T cells from T-bet CD2-Tg mice (and BALB/c wild type controls) were stimulated in vitro under Th0 (A) and Th1-polarizing conditions (B). After one round of restimulation, T cells were stimulated and then stained with mAbs to Tim-3 and CD4, and cytokine expression was detected by intracellular staining. Histograms represent Tim-3 expression (dotted line, isotype control; solid line, specific staining). Dot plots represent cytokine expression in CD4+ T cells (Th1 condition). This experiment was repeated 3 times (n=4 for both wildtype and Tg mice in each experiment). Representative data are shown.
Figure 5
Figure 5. T-bet controls Tim-3 expression in vivo
1 × 106 naive (CD4+CD62LhighCD44lowCD25) CD4+ T cells from wildtype (Balb/c) or T-bet−/− (Balb/c) were adoptively transferred i.v. into Rag2−/− (Balb/c) mice (n=5/group). Transferred mice were administered Brdu in the drinking water (0.8mg/ml). Two weeks later, splenic T cells populations were harvested. (A) Frequency of CD4+Brdu+ cells in transferred mice. (B) Frequency of CD4+CD25+ cells in transferred mice. (C) Frequency of total CD4+Tim-3+ cells in transferred mice. Error bars indicate SEM. Data shown are representative of 2 independent experiments.
Figure 6
Figure 6. T-bet binds to the Tim-3 promoter in vivo
ChIP was performed on murine Th1 CD4+ T cells with a polyclonal antibody to T-bet, and the resulting genomic DNA was analyzed by real-time PCR. (A) IFN-γ promoter, (B) IL-4 promoter, (C) Tim-3 promoter and (D) Tim-3 promoter after ChIP with a STAT-4 antibody. Enrichment is expressed as the fold enrichment of IP DNA over whole cell extract. Error bars indicate SEM of triplicate reactions. Data shown are representative of 2 independent experiments.

References

    1. Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, Chernova T, Manning S, Greenfield EA, Coyle AJ, Sobel RA, Freeman GJ, Kuchroo VK. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature. 2002;415:536–541. - PubMed
    1. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, Zheng XX, Strom TB, Kuchroo VK. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol. 2005;6:1245–1252. - PubMed
    1. Sabatos CA, Chakravarti S, Cha E, Schubart A, Sanchez-Fueyo A, Zheng XX, Coyle AJ, Strom TB, Freeman GJ, Kuchroo VK. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol. 2003;4:1102–1110. - PubMed
    1. Sanchez-Fueyo A, Tian J, Picarella D, Domenig C, Zheng XX, Sabatos CA, Manlongat N, Bender O, Kamradt T, Kuchroo VK, Gutierrez-Ramos JC, Coyle AJ, Strom TB. TIM-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol. 2003;4:1093–1101. - PubMed
    1. Anderson AC, Anderson DE, Bregoli L, Hastings WD, Kassam N, Lei C, Chandwaskar R, Karman J, Su EW, Hirashima M, Bruce JN, Kane LP, Kuchroo VK, Hafler DA. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science. 2007;318:1141–1143. - PubMed

Publication types

MeSH terms

LinkOut - more resources